AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trazumab 150mg Injection

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Trastuzumab (150mg)

Overview Trazumab 150mg Injection

Herceptin (trastuzumab) 150mg injection is indicated for breast and gastric cancers. Its mechanism involves targeting and eliminating cancerous cells by blocking HER2, a protein crucial for tumor growth. Administration is exclusively via injection by a healthcare professional, with dosage and frequency determined by your physician based on individual needs and treatment response. Strict adherence to the prescribed regimen is vital; incorrect usage or overdose can lead to severe adverse reactions. While benefits may not be immediately apparent (taking several weeks or months), discontinuation is only permissible under medical guidance. Common side effects include nausea, headaches, skin rashes, sleep disturbances, and increased infection risk. This medication can lower blood cell counts, enhancing vulnerability to infections, necessitating regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all other medications you're taking due to potential interactions. Use during pregnancy or breastfeeding is contraindicated; effective birth control for both partners is crucial throughout the treatment period.

Uses of Trazumab 150mg Injection

Cancers affecting the breast and stomach

Major Benefits of Trazumab 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Trazumab 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Trazumab 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Trazumab 150mg Injection works:

The injectable formulation, Trastuzumab 150mg, is a genetically engineered monoclonal antibody of the IgG1 class. This medication targets HER2, the human epidermal growth factor receptor 2 protein, which drives excessive cell growth in breast and gastric cancers. Trastuzumab neutralizes HER2, leading to cancer cell death, and concurrently blocks multiple downstream signaling cascades that promote tumor development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Trazumab 150mg Injection and alcohol may induce pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Trastuzumab 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Patient consultation with their doctor is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Trazumab 150mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Trazumab 150mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney impairment, Trastuzumab 150mg injection is likely safe. Existing evidence indicates dose modification may be unnecessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Trazumab 150mg Injection to individuals with hepatic impairment. Seek medical advice from your physician.

What if you forget to take Trazumab 150mg Injection :

Omit a Trazumab 150mg Injection dose? Seek your physician's advice.

Facts to Know About Trazumab 150mg Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Type of Therapy Cancer Medications
Action Class Monoclonal antibody HER2/neu (ErbB2) inhibitor

FAQs on Trazumab 150mg Injection

Trazumab 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, appetite loss, rapid heartbeat, urine discoloration, decreased or painful urination, difficulty urinating, and signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Women of childbearing age must use effective contraception throughout Trastuzumab 150mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Treatment with Trastuzumab 150mg Injection should continue for one year in patients with early-stage breast cancer, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Trastuzumab 150mg Injection doesn't require fasting beforehand. Administration must be supervised by a physician experienced in cancer chemotherapy and performed only by a qualified healthcare professional.
Trazumab 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the correct formulation is administered as prescribed, as the IV formulation is for intravenous use only. Your doctor may change your treatment between IV and SC Trazumab 150mg Injection if clinically appropriate.
Trastuzumab 150mg Injection is a monoclonal antibody targeting the HER2 protein, abundant on the surface of some cancer cells. Its mechanism involves binding to HER2, inhibiting cancer cell growth and spread. Consequently, this injection is only effective, and thus indicated, for patients with HER2-positive cancer; it's ineffective in HER2-negative cases.
Using Trastuzumab 150mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations should begin at treatment initiation, continue every three months throughout treatment, and then every six months post-treatment for up to 24 months following the final Trastuzumab 150mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every twelve weeks.
Trazumab 150mg Injection
24,096